Anne Brindley
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Anne Brindley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
29
| Public Company | Pharmaceuticals: Major | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anne Brindley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Glaxo, Inc. | Chairman Chief Tech/Sci/R&D Officer | ||
| University of Bristol | College/University | Doctorate Degree Undergraduate Degree | |
| LIPOSCIENCE INC | Medical Specialties | Chairman Founder | |
| St. John's University | College/University | Undergraduate Degree Undergraduate Degree | |
| AWAKN LIFE SCIENCES CORP. | Medical/Nursing Services | Director/Board Member | |
Concentric Analgesics, Inc.
 Concentric Analgesics, Inc. Packaged SoftwareTechnology Services Concentric Analgesics, Inc. develops novel, non-opioid therapeutics for the management of acute postsurgical and chronic osteoarthritis pain. The company was founded by John F. Donovan, Frank J. Bellizzi and Craig O. Husfeld in 2014 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
| IMMATICS N.V. | Biotechnology | Director/Board Member | |
| PRESTIGE CONSUMER HEALTHCARE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
| University of West London | College/University | Undergraduate Degree | |
| HUTCHMED (CHINA) LIMITED | Pharmaceuticals: Major | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| Université Catholique de Louvain | College/University | Graduate Degree | |
Reckitt Benckiser Healthcare International Ltd.
 Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Household/Personal Care | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Masters Business Admin | |
| University of Alabama Medical Center | Corporate Officer/Principal | ||
| The College of William & Mary | College/University | Undergraduate Degree | |
| University of Florida | College/University | Doctorate Degree | |
River Logic, Inc.
 River Logic, Inc. Packaged SoftwareTechnology Services River Logic, Inc. provides corporate performance management and advanced predictive modeling solutions. Its Enterprise Optimizer technology platform supports a range of solutions that include Cost-to-Serve Planner, Integrated Business Planner, Trade Promotion Optimization Planner, and Network Design and Optimization Planner. The firm?s Enterprise Optimizer (EO) based products include EO Workstation, EO Research, EO Server, EO Integrated Business Planning (IBP) Framework, and Prescriptive Analytics. It operates through its offices located in Beverly and Dallas. The company was founded by by Robert C. Whitehair in 2000 and is headquartered in Dallas, TX. | Packaged Software | Director/Board Member | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Executive Officer | |
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | President | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
| CHIASMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Biointervene, Inc.
 Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Scleroderma Research Foundation
 Scleroderma Research Foundation BiotechnologyHealth Technology The Scleroderma Research Foundation is a non-profit organization that funds research for scleroderma, a potentially life-threatening illness. The non-profit company is based in San Francisco, CA. Established in 1987 by a patient-turned-activist, the foundation is the largest investor in scleroderma research. The foundation's goal is to find a cure for the disease by bringing together the best minds in science. The SRF has invested over $39 million dollars to date in scleroderma research, funding and facilitating research at top institutions such as Johns Hopkins University School of Medicine, Stanford University, and the University of California. | Biotechnology | Consultant / Advisor | |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | President | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Iowa | College/University | Undergraduate Degree | |
Epigenesis Pharmaceuticals LLC
 Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Other | President | |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 35 |
| Vereinigtes Königreich | 8 |
| Kanada | 3 |
| Schweiz | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Technology Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 92 |
| Corporate Officer/Principal | 70 |
| Chairman | 36 |
| Chief Tech/Sci/R&D Officer | 27 |
| Independent Dir/Board Member | 25 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Charlie Sanders | 38 |
| Richard Sykes | 37 |
| Richard A. Franco | 17 |
| Gary Patou | 17 |
| Don Soland | 14 |
| Paul W. Hawran | 13 |
| Paul Carter | 12 |
| Alex Howarth | 11 |
| Kristi L. Meints | 11 |
| Carol Ashe | 9 |
| Scott Fields | 9 |
| Leon Palandjian | 8 |
| David Redfern | 8 |
| William Louv | 8 |
| James Ford | 7 |
- Börse
- Insiders
- Anne Brindley
- Unternehmensverbindungen
